AORT vs INMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

AORT

32.3
AI Score
VS
INMD Wins

INMD

58.7
AI Score

Investment Advisor Scores

AORT

32score
Recommendation
SELL

INMD

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AORT INMD Winner
Revenue 441.33M 370.50M AORT
Net Income 9.77M 93.83M INMD
Gross Margin 64.4% 78.5% INMD
Net Margin 2.2% 25.3% INMD
Operating Income 33.74M 85.39M INMD
ROE 2.2% 13.7% INMD
ROA 1.1% 12.2% INMD
Total Assets 884.80M 766.43M AORT
Cash 64.91M 302.54M INMD
Current Ratio 3.53 9.88 INMD
Free Cash Flow 839,000 84.28M INMD

Relative Price Performance (Last 90 Days)

AORT 1M: +12.3% · 3M: +23.3% INMD 1M: -0.2% · 3M: +8.9%

Current Technical Phase

AORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $28.08

INMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $15.06

Fundamentals Snapshot

Metric AORT INMD
Market Cap
Forward P/E 35.9 11.0
Trailing P/E 12.4
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.1%
EPS -0.06 1.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, INMD is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.